Fast Market Research

New Market Report Now Available: Pharis Biotec GmbH - Product Pipeline Review - 2013

New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research


Boston, MA -- (SBWIRE) -- 09/04/2013 -- Global Markets Direct's pharmaceuticals report, "Pharis Biotec GmbH - Product Pipeline Review - 2013" provides data on the Pharis Biotec GmbH's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Pharis Biotec GmbH's corporate website, SEC filings, investor presentations and featured press releases, both from Pharis Biotec GmbH and industry-specific third party sources, put together by Global Markets Direct's team.


- Pharis Biotec GmbH - Brief Pharis Biotec GmbH overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Pharis Biotec GmbH human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Pharis Biotec GmbH with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Pharis Biotec GmbH's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Pharis Biotec GmbH's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Pharis Biotec GmbH in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Pharis Biotec GmbH's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Pharis Biotec GmbH.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Pharis Biotec GmbH and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Pharis Biotec GmbH - Product Pipeline Review - 2012
- AiCuris GmbH & Co. KG - Product Pipeline Review - 2013
- Grunenthal GmbH - Product Pipeline Review - 2013
- RESprotect GmbH - Product Pipeline Review - 2013
- Glycotope GmbH - Product Pipeline Review - 2013
- Vakzine Projekt Management GmbH - Product Pipeline Review - 2013
- Biotec Pharmacon ASA - Product Pipeline Review - 2013
- PARI Pharma GmbH - Product Pipeline Review - 2013
- Dermatitis - Pipeline Review, H1 2013
- JADO Technologies GmbH - Product Pipeline Review - 2013